The IGF-1R (insulin-like growth factor 1 receptor) protein level, which has been associated with resistance to EGFR-TKIs, was also analyzed to explore the potential mechanisms behind the effects of the GAS5/gefitinib combination on gefitinib-resistant lung adenocarcinoma cells. The gene discussed is EGFR; the disease is lung adenocarcinoma.